Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The glycobiology market was valued at USD 1.99 Billion in 2025. It is poised to grow at a CAGR of 15.20% during the forecast period of 2026-2035, reaching USD 8.19 Billion by 2035. The market is driven by rising pharmaceutical investments in glycomics and glycan analysis, increasing prevalence of chronic diseases, and expanding applications of glycosylation research in drug discovery and diagnostics.
Compound Annual Growth Rate
15.2%
Value in USD Billion
2026-2035
Read more about this report - Request a Free Sample
Glycobiology, also referred to as glycomics, is the study of the structure, composition, and function of carbohydrates (glycans) in living organisms. These complex molecules govern critical biological processes, including cell signaling, immune response, protein stability, and pathogen recognition. The market was valued at USD 1.99 Billion in 2025. The market is propelled by robust pharmaceutical and biotechnology investment in glycan profiling, expanding clinical applications of glycoprotein analysis, and the growing integration of artificial intelligence with mass spectrometry platforms in glycoscience workflows.
Rising Prevalence of Chronic Diseases is Accelerating Investment in Glycomics and Drug Discovery Applications to Boost the Market Demand
The growing global burden of cancer, autoimmune disorders, and metabolic diseases is a primary catalyst for glycobiology market expansion. According to the World Health Organization (WHO), approximately 20 million new cancer cases were recorded in 2022, representing a 77% increase, with over 35 million new cases in 2050, driving pharmaceutical companies to invest heavily in glycan biomarkers for early detection and targeted therapy development. Glycans regulate tumor cell behavior and immune evasion, making them pivotal targets in oncology research.
The market is witnessing several key trends, including growing collaboration between industry and academia.
Growing Industry-Academia Collaborations to Propel the Market Value
Increasing collaboration between academic institutions and industry players is emerging as a key trend shaping advancements in glycobiology research. These partnerships are enabling interdisciplinary innovation, particularly in areas such as plant science, microbiology, and bioactive compound analysis. For instance, in October 2025, Okayama University partnered with Nagase Viita Co., Ltd. to establish a dedicated glycobiology research laboratory focused on sustainable applications. Such initiatives are expected to accelerate innovation and support sustained market growth.
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Enzymes Segment Leads the Glycobiology Market by Product
The enzymes segment is expected to lead the market, as enzymes are indispensable tools for synthesizing, modifying, and degrading glycans in research and biopharmaceutical production settings. Key enzyme classes, including glycosidases and glycosyltransferases, are widely used in glycan profiling, glycoprotein engineering, and quality control workflows for biological drugs. Their essential role in decoding glycosylation patterns and validating glycan biomarkers makes them a recurring procurement priority for both academic institutions and pharmaceutical companies, sustaining the segment's market leadership throughout the forecast period.
Read more about this report - Request a Free Sample
The regions included in the market are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America is anticipated to witness significant growth in the market, supported by substantial NIH funding, a dense biopharma ecosystem, and the presence of key players. Asia Pacific is the fastest-growing region, propelled by rising healthcare investments in China, India, and Japan, and expanding academic-industry research collaborations in glycomics.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Merck KGaA is a German science and technology company with deep expertise in life sciences, pharmaceuticals, and performance materials. In the glycobiology market, Merck offers analytical tools for glycan profiling, glycoprotein purification, and glycosylation analysis. In April 2024, Merck launched its AI-enhanced GlycoProfile platform for high-throughput glycan screening, serving biopharma clients across 60 countries.
Thermo Fisher Scientific Inc. is a United States-based global leader in analytical instruments, reagents, and life science research tools. The company's glycobiology portfolio spans mass spectrometry systems, glycan analysis kits, and enzymes for drug discovery. Through strategic collaborations, including partnerships with TransMIT GmbH and OwlStone Medical, Thermo Fisher supports advanced glycomics workflows for biopharmaceutical development.
Shimadzu Corporation is a Japanese precision instruments manufacturer with a significant presence in the glycobiology market through its advanced mass spectrometry and liquid chromatography platforms. Its LCMS-9030 Q-TOF system supports high-resolution glycan analysis and glycomics data interpretation. Shimadzu serves pharmaceutical, biotechnology, and academic clients across North America, Europe, and Asia Pacific, contributing to glycoprotein characterization workflows.
Takara Bio Inc. is a Japan-based biotechnology company specialising in life science research tools including glycomics reagents and glycan analysis kits. The company has continuously expanded its glycobiology product portfolio to support researchers in glycan labelling, release, and purification applications. Takara Bio serves academic institutes, pharmaceutical companies, and CROs globally, with a strong foothold in the Asia Pacific research market.
Other key players include Promega Corporation, Danaher Corporation, AMS Bio, Sumitomo Bakelite Co. Ltd., Dextra Laboratories Ltd., RayBiotech, Inc., Waters Corporation, New England Biolabs, Inc., and Glycotope GmbH.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.